54 related articles for article (PubMed ID: 35436142)
1. Comparison of preventive effects of combined furosemide and mannitol versus single diuretics, furosemide or mannitol, on cisplatin-induced nephrotoxicity.
Takagi A; Miyoshi T; Hayashi T; Koizumi H; Tsumagari K; Yokota C; Nakano T; Matsuo K; Egawa T
Sci Rep; 2024 May; 14(1):10511. PubMed ID: 38714773
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: which dose is more suitable?
Ilhan Y; Onder AH; Ozbay MF; Karakaya G; Sezgin Goksu S; Ozturk B; Coskun HS
Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3403-3413. PubMed ID: 38766796
[TBL] [Abstract][Full Text] [Related]
3. Magnesium supplementation therapy to prevent cisplatin-induced acute nephrotoxicity in pediatric cancer: a randomized phase-2 trial.
Matsui M; Makimoto A; Chin M; Koh K; Tomotsune M; Kaneko T; Morikawa Y; Hamada R; Yuza Y
Int J Clin Oncol; 2024 May; 29(5):629-637. PubMed ID: 38564107
[TBL] [Abstract][Full Text] [Related]
4. Long-term cisplatin nephrotoxicity after childhood cancer: a systematic review and meta-analysis.
Schofield J; Harcus M; Pizer B; Jorgensen A; McWilliam S
Pediatr Nephrol; 2024 Mar; 39(3):699-710. PubMed ID: 37726572
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Dextrose Hypotonic vs Saline Hydration on Methotrexate-Induced Nephrotoxicity in Male and Female Rats.
Hasanpour Z; Choopani S; Ashrafi F; Talebi A; Nematbaksh M
Adv Biomed Res; 2024; 13():14. PubMed ID: 38525397
[TBL] [Abstract][Full Text] [Related]
6. Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review.
Zazuli Z; Vijverberg S; Slob E; Liu G; Carleton B; Veltman J; Baas P; Masereeuw R; Maitland-van der Zee AH
Front Pharmacol; 2018; 9():1111. PubMed ID: 30319427
[No Abstract] [Full Text] [Related]
7. Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin-based chemotherapy using short hydration: A randomized phase II trial.
Murakami E; Akamatsu H; Teraoka S; Takakura T; Takase E; Tanaka M; Kaki T; Harutani Y; Furuta K; Sugimoto T; Shibaki R; Fujimoto D; Hayata A; Ozawa Y; Nakanishi M; Koh Y; Shimokawa T; Yamamoto N
Cancer Med; 2024 Feb; 13(4):e6839. PubMed ID: 38457231
[TBL] [Abstract][Full Text] [Related]
8. Vaccarin alleviates cisplatin-induced acute kidney injury via decreasing NOX4-derived ROS.
Wu T; Ma W; Lu W; Huangshen Z; Chen S; Yang Q; Li C; Li Z; Li N; Feng X; Li L; Miao Y; Wang J; Liu X; Cai Y; He Y; He X; Li J; Zhao R; Wen J
Heliyon; 2023 Nov; 9(11):e21231. PubMed ID: 38027630
[TBL] [Abstract][Full Text] [Related]
9. Hydration Methods for Cisplatin Containing Chemotherapy: A Systematic Review.
Sikking C; Niggebrugge-Mentink KL; van der Sman ASE; Smit RHP; Bouman-Wammes EW; Beex-Oosterhuis MM; van Kesteren C
Oncologist; 2024 Feb; 29(2):e173-e186. PubMed ID: 37995306
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin in Liver Cancer Therapy.
Hamaya S; Oura K; Morishita A; Masaki T
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446035
[TBL] [Abstract][Full Text] [Related]
11. Crystalloid Solutions in Hospital: A Review of Existing Literature.
Panchal V; Sivasubramanian BP; Samala Venkata V
Cureus; 2023 May; 15(5):e39411. PubMed ID: 37362468
[TBL] [Abstract][Full Text] [Related]
12. Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity.
Domingo IK; Latif A; Bhavsar AP
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806229
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Intravenous Mannitol Combined With Normal Saline in Preventing Cisplatin-Induced Nephrotoxicity: A Randomized, Double-Blind, Placebo-Controlled Trial.
Sainamthip P; Saichaemchan S; Satirapoj B; Prasongsook N
JCO Glob Oncol; 2022 Mar; 8():e2100275. PubMed ID: 35436142
[TBL] [Abstract][Full Text] [Related]
14. Mannitol to prevent cisplatin-induced nephrotoxicity in patients with squamous cell cancer of the head and neck (SCCHN) receiving concurrent therapy.
McKibbin T; Cheng LL; Kim S; Steuer CE; Owonikoko TK; Khuri FR; Shin DM; Saba NF
Support Care Cancer; 2016 Apr; 24(4):1789-93. PubMed ID: 26446698
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effect of acetazolamide versus mannitol on cisplatin-induced nephrotoxicity, a pilot study.
El Hamamsy M; Kamal N; Bazan NS; El Haddad M
Int J Clin Pharm; 2018 Dec; 40(6):1539-1547. PubMed ID: 30167970
[TBL] [Abstract][Full Text] [Related]
16. Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial.
Santoso JT; Lucci JA; Coleman RL; Schafer I; Hannigan EV
Cancer Chemother Pharmacol; 2003 Jul; 52(1):13-8. PubMed ID: 12719883
[TBL] [Abstract][Full Text] [Related]
17. The ability of mannitol to decrease cisplatin-induced nephrotoxicity in children: real or not?
Ruggiero A; Rizzo D; Trombatore G; Maurizi P; Riccardi R
Cancer Chemother Pharmacol; 2016 Jan; 77(1):19-26. PubMed ID: 26589789
[TBL] [Abstract][Full Text] [Related]
18. The role of mannitol as a nephroprotectant in patients receiving cisplatin therapy.
Morgan KP; Buie LW; Savage SW
Ann Pharmacother; 2012 Feb; 46(2):276-81. PubMed ID: 22298599
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]